Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
VCAP-AMP-VECP regimen
Introduction
Overview
Overview
VCAP-AMP-VECP regimen refers to a regimen consisting of with vincristine, cyclophosphamide, doxorubicin (adriamycin), and prednisone (VCAP), doxorubicin (adriamycin), ranimustine, and prednisone (AMP), and vindesine, etoposide, carboplatin, and prednisone (VECP) used to treat human T-lymphotropic virus type I-associated adult T-cell leukemia-lymphoma (ATLL)[1]
Regimen
Regimen
VVincristine
CCyclophosphamide
ADoxorubicin (Adriamycin)
PPrednisone
ADoxorubicin (Adriamycin)
MRanimustine (MCNU)
PPrednisone
VVindesine
EEtoposide
CCarboplatin
PPrednisone
Indications
Indications
- Human T-lymphotropic virus type I-associated Adult T-cell leukemia-lymphoma (ATLL)[1]
References
References
- ↑ 1.0 1.1 Tsukasaki K, Utsunomiya A, Fukuda H, Shibata T, Fukushima T, Takatsuka Y; et al. (2007). “VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801”. J Clin Oncol. 25 (34): 5458–64. doi:10.1200/JCO.2007.11.9958. PMID 17968021.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]